REVIEW Overlapping Protein Accumulation Pro fi les of CADASIL and CAA Is There a Common Mechanism Driving Cerebral Small-Vessel Disease?

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) and cerebral amyloid angiopathy (CAA) are two distinct vascular angiopathies that share several similarities in clinical presentation and vascular pathology. Given the clinical and pathologic overlap, the molecular overlap between CADASIL and CAAwas explored. CADASIL and CAA proteinpro fi lesfrom recently published proteomics-based and immuno-based studies were compared to investigate the potential for shared disease mechanisms. A comparison of affected proteins in each disease highlighted 19 proteins that are regulated in both CADASIL and CAA. Functional analysis of the shared proteins predicts signi fi cant interaction between them and suggests that most enriched proteins play roles in extracellular matrix structure and remodeling. Proposed models to explain the observed enrichment of extracellular matrix proteins include both increased protein secretion and decreased protein turnover by sequestration of chaperonesandproteasesorformationofstableproteincomplexes.Single-cellRNAsequencingofvascularcellsinmicesuggestedthatthevastmajorityofthegenesaccountingfortheoverlappedproteinsbetween CADASIL and CAA are expressed by fi broblasts. Thus, our current understanding of the molecular pro fi les of CADASIL and CAA appears to support potential for common mechanisms underlying the two disorders.

[1]  M. Verbeek,et al.  Disturbed balance in the expression of MMP9 and TIMP3 in cerebral amyloid angiopathy-related intracerebral haemorrhage , 2020, Acta Neuropathologica Communications.

[2]  M. Ivanova,et al.  Thiol-mediated and catecholamine-enhanced multimerization of a cerebrovascular disease enriched fragment of NOTCH3 , 2020, Experimental Neurology.

[3]  Sung-Chun Tang,et al.  Plasma neurofilament light chain and glial fibrillary acidic protein predict stroke in CADASIL , 2020, Journal of Neuroinflammation.

[4]  C. Haffner Proteostasis in Cerebral Small Vessel Disease , 2019, Front. Neurosci..

[5]  C. Sigurdson,et al.  Cryo-EM structure and polymorphism of Aβ amyloid fibrils purified from Alzheimer’s brain tissue , 2019, Nature Communications.

[6]  Damian Szklarczyk,et al.  STRING v11: protein–protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets , 2018, Nucleic Acids Res..

[7]  A. Tuttolomondo,et al.  β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage , 2018, Oncotarget.

[8]  H. Vinters,et al.  The effects of cerebral amyloid angiopathy on integrity of the blood-brain barrier , 2018, Neurobiology of Aging.

[9]  Ying Sun,et al.  Single-cell RNA sequencing of mouse brain and lung vascular and vessel-associated cell types , 2018, Scientific Data.

[10]  Michael M. Wang,et al.  Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy , 2018, Translational Stroke Research.

[11]  A. Smit,et al.  Proteomics analysis identifies new markers associated with capillary cerebral amyloid angiopathy in Alzheimer’s disease , 2018, Acta neuropathologica communications.

[12]  M. Dichgans,et al.  CADASIL brain vessels show a HTRA1 loss-of-function profile , 2018, Acta Neuropathologica.

[13]  Koji Ando,et al.  A molecular atlas of cell types and zonation in the brain vasculature , 2018, Nature.

[14]  J. Montaner,et al.  Systematic Review of Cysteine-Sparing NOTCH3 Missense Mutations in Patients with Clinical Suspicion of CADASIL , 2017, International journal of molecular sciences.

[15]  T. Kawano,et al.  Serum amyloid P component: A novel potential player in vessel degeneration in CADASIL , 2017, Journal of the Neurological Sciences.

[16]  Karsten Melcher,et al.  Amyloid beta: structure, biology and structure-based therapeutic development , 2017, Acta Pharmacologica Sinica.

[17]  C. Ayata,et al.  Emerging concepts in sporadic cerebral amyloid angiopathy. , 2017, Brain : a journal of neurology.

[18]  M. van Buchem,et al.  TGFβ pathway deregulation and abnormal phospho‐SMAD2/3 staining in hereditary cerebral hemorrhage with amyloidosis‐Dutch type , 2017, Brain pathology.

[19]  N. De Stefano,et al.  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) as a model of small vessel disease: update on clinical, diagnostic, and management aspects , 2017, BMC Medicine.

[20]  H. Boutin,et al.  Early changes in extracellular matrix in Alzheimer's disease , 2017, Neuropathology and applied neurobiology.

[21]  J. Attems,et al.  Systems proteomic analysis reveals that clusterin and tissue inhibitor of metalloproteinases 3 increase in leptomeningeal arteries affected by cerebral amyloid angiopathy , 2016, Neuropathology and applied neurobiology.

[22]  J. van der Grond,et al.  Archetypal NOTCH3 mutations frequent in public exome: implications for CADASIL , 2016, Annals of clinical and translational neurology.

[23]  R. Nitsch,et al.  Tau pathology-dependent remodelling of cerebral arteries precedes Alzheimer’s disease-related microvascular cerebral amyloid angiopathy , 2016, Acta Neuropathologica.

[24]  H. Stöhr,et al.  Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice , 2016, Annals of neurology.

[25]  Guojun Bu,et al.  The role of APOE in cerebrovascular dysfunction , 2016, Acta Neuropathologica.

[26]  M. Nelson,et al.  Perturbations of the cerebrovascular matrisome: A convergent mechanism in small vessel disease of the brain? , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[27]  Martin Dichgans,et al.  Genetic factors in cerebral small vessel disease and their impact on stroke and dementia , 2016, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  M. Tamura,et al.  Characteristic features and progression of abnormalities on MRI for CARASIL , 2015, Neurology.

[29]  M. Dichgans,et al.  Cysteine-Sparing CADASIL Mutations in NOTCH3 Show Proaggregatory Properties In Vitro , 2015, Stroke.

[30]  Michael M. Wang,et al.  The Small Leucine-Rich Proteoglycan BGN Accumulates in CADASIL and Binds to NOTCH3 , 2015, Translational Stroke Research.

[31]  M. Yamada Cerebral Amyloid Angiopathy: Emerging Concepts , 2015, Journal of stroke.

[32]  E. Dere,et al.  Hypertension Accelerates the Progression of Alzheimer-Like Pathology in a Mouse Model of the Disease , 2015, Hypertension.

[33]  M. Geschwind,et al.  Latent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state , 2014, Brain Research.

[34]  R. Carare,et al.  The Cerebrovascular Basement Membrane: Role in the Clearance of β-amyloid and Cerebral Amyloid Angiopathy , 2014, Front. Aging Neurosci..

[35]  Michael M. Wang,et al.  Vascular accumulation of the small leucine-rich proteoglycan decorin in CADASIL , 2014, Neuroreport.

[36]  M. Dichgans,et al.  Sequestration of latent TGF-β binding protein 1 into CADASIL-related Notch3-ECD deposits , 2014, Acta neuropathologica communications.

[37]  C. Feghali-Bostwick,et al.  Fibroblasts in fibrosis: novel roles and mediators , 2014, Front. Pharmacol..

[38]  A. Joutel,et al.  Early white matter changes in CADASIL: evidence of segmental intramyelinic oedema in a pre-clinical mouse model , 2014, Acta neuropathologica communications.

[39]  John R. Yates,et al.  Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures , 2013, Cell.

[40]  A. Joutel,et al.  Abnormal recruitment of extracellular matrix proteins by excess Notch3 ECD: a new pathomechanism in CADASIL. , 2013, Brain : a journal of neurology.

[41]  Michael M. Wang,et al.  Advanced Intimal Hyperplasia Without Luminal Narrowing of Leptomeningeal Arteries in CADASIL , 2013, Stroke.

[42]  J. Attems,et al.  Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. , 2013, Journal of neuropathology and experimental neurology.

[43]  J. Bol,et al.  Tissue transglutaminase colocalizes with extracellular matrix proteins in cerebral amyloid angiopathy , 2013, Neurobiology of Aging.

[44]  R. Carare,et al.  Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid‐β from the mouse brain , 2013, Aging cell.

[45]  Jean-Baptiste Michel,et al.  The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles. , 2012, Cardiovascular research.

[46]  Michael M. Wang,et al.  Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy , 2012, Brain Research.

[47]  À. Rovira,et al.  MMP‐2/MMP‐9 Plasma Level and Brain Expression in Cerebral Amyloid Angiopathy‐Associated Hemorrhagic Stroke , 2012, Brain pathology.

[48]  H. D. de Vries,et al.  Neuroinflammation and Blood-Brain Barrier Changes in Capillary Amyloid Angiopathy , 2012, Neurodegenerative Diseases.

[49]  Michael M. Wang Notch signaling and Notch signaling modifiers. , 2011, The international journal of biochemistry & cell biology.

[50]  Michael M. Wang,et al.  von Willebrand Factor Permeates Small Vessels in CADASIL and Inhibits Smooth Muscle Gene Expression , 2011, Translational Stroke Research.

[51]  E. Kremmer,et al.  Co-aggregate formation of CADASIL-mutant NOTCH3: a single-particle analysis. , 2011, Human molecular genetics.

[52]  H. D. de Vries,et al.  Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy. , 2011, Antioxidants & redox signaling.

[53]  S. Gygi,et al.  Hypomorphic Notch 3 alleles link Notch signaling to ischemic cerebral small-vessel disease , 2011, Proceedings of the National Academy of Sciences.

[54]  K. Jellinger,et al.  Review: Sporadic cerebral amyloid angiopathy , 2011, Neuropathology and applied neurobiology.

[55]  Huaxi Xu,et al.  APP processing in Alzheimer's disease , 2011, Molecular Brain.

[56]  S. Greenberg,et al.  Prevalence of Superficial Siderosis in Patients with Cerebral Amyloid Angiopathy , 2010, Neurology.

[57]  C. Ayata CADASIL: experimental insights from animal models. , 2010, Stroke.

[58]  J. Choi Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy: A Genetic Cause of Cerebral Small Vessel Disease , 2010, Journal of clinical neurology.

[59]  A. Schedl,et al.  Cerebrovascular dysfunction and microcirculation rarefaction precede white matter lesions in a mouse genetic model of cerebral ischemic small vessel disease. , 2010, The Journal of clinical investigation.

[60]  M. Dichgans,et al.  CADASIL mutations enhance spontaneous multimerization of NOTCH3. , 2009, Human molecular genetics.

[61]  M. Dichgans,et al.  CADASIL , 2009, The Lancet Neurology.

[62]  M. Dichgans,et al.  Distinct phenotypic and functional features of CADASIL mutations in the Notch3 ligand binding domain. , 2009, Brain : a journal of neurology.

[63]  L. Lue,et al.  ABCG2 Is Upregulated in Alzheimer's Brain with Cerebral Amyloid Angiopathy and May Act as a Gatekeeper at the Blood–Brain Barrier for Aβ1–40 Peptides , 2009, The Journal of Neuroscience.

[64]  Berislav V. Zlokovic,et al.  Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease , 2009, Acta Neuropathologica.

[65]  G. Zipfel,et al.  Cerebral Amyloid Angiopathy: Progressive Disruption of the Neurovascular Unit , 2009, Stroke.

[66]  R O Weller,et al.  Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: significance for cerebral amyloid angiopathy and neuroimmunology , 2008, Neuropathology and applied neurobiology.

[67]  R. Carare,et al.  Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. , 2008, Brain pathology.

[68]  S. Salloway,et al.  Cerebral Cortical Arteriolar Angiopathy, Vascular Beta-Amyloid, Smooth Muscle Actin, Braak Stage, and APOE Genotype , 2008, Stroke.

[69]  Jin-Moo Lee,et al.  Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ* , 2006, Journal of Biological Chemistry.

[70]  D. Mann,et al.  Relationships in Alzheimer's disease between the extent of Aβ deposition in cerebral blood vessel walls, as cerebral amyloid angiopathy, and the amount of cerebrovascular smooth muscle cells and collagen , 2006 .

[71]  H. Markus,et al.  The spatial distribution of MR imaging abnormalities in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy and their relationship to age and clinical features. , 2005, AJNR. American journal of neuroradiology.

[72]  P. Libby,et al.  CADASIL mutations impair Notch3 glycosylation by Fringe. , 2005, Human molecular genetics.

[73]  B. Klonjkowski,et al.  Notch3 is required for arterial identity and maturation of vascular smooth muscle cells. , 2004, Genes & development.

[74]  M. Viitanen,et al.  Fibrosis and Stenosis of the Long Penetrating Cerebral Arteries: the Cause of the White Matter Pathology in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy , 2004, Brain pathology.

[75]  M. Dichgans,et al.  CADASIL-associated Notch3 mutations have differential effects both on ligand binding and ligand-induced Notch3 receptor signaling through RBP-Jk. , 2004, Experimental cell research.

[76]  Norman J Beauchamp,et al.  White Matter Hyperintensity on Cranial Magnetic Resonance Imaging: A Predictor of Stroke , 2004, Stroke.

[77]  K. Welsh-Bohmer,et al.  Vascular Smooth Muscle Actin Is Reduced in Alzheimer Disease Brain: A Quantitative Analysis , 2004, Journal of neuropathology and experimental neurology.

[78]  R. Weller,et al.  Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer’s disease Pro-CAA position statement , 2004, Neurobiology of Aging.

[79]  T. Saido,et al.  Dutch, Flemish, Italian, and Arctic mutations of APP and resistance of Aβ to physiologically relevant proteolytic degradation , 2003, The Lancet.

[80]  Eduardo A. Fierro Structures , 2003, Composite Architecture.

[81]  U. Lendahl,et al.  A CADASIL-mutated Notch 3 receptor exhibits impaired intracellular trafficking and maturation but normal ligand-induced signaling , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[82]  K. Arima,et al.  Arterial Changes in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) in Relation to Pathogenesis of Diffuse Myelin Loss of Cerebral White Matter: Examination of Cerebral Medullary Arteries by Reconstruction of Serial Sections of an Autopsy Case , 2002, Stroke.

[83]  G. Weinmaster,et al.  Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels , 2001, Mechanisms of Development.

[84]  J. Wegiel,et al.  Role of Perivascular Cells and Myocytes in Vascular Amyloidosis , 2000, Annals of the New York Academy of Sciences.

[85]  M. Dichgans,et al.  Small in-frame deletions and missense mutations in CADASIL: 3D models predict misfolding of Notch3v EGF-like repeat domains , 2000, European Journal of Human Genetics.

[86]  F. Chapon,et al.  The ectodomain of the Notch3 receptor accumulates within the cerebrovasculature of CADASIL patients. , 2000, The Journal of clinical investigation.

[87]  M. Hudon,et al.  Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) , 1999, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[88]  S. Downes,et al.  Regulation of Cell Surface Tissue Transglutaminase: Effects on Matrix Storage of Latent Transforming Growth Factor-β Binding Protein-1 , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[89]  Y. Olsson,et al.  Amyloid angiopathy of the human brain: immunohistochemical studies using markers for components of extracellular matrix, smooth muscle actin and endothelial cells , 1998, Acta Neuropathologica.

[90]  M. Dichgans,et al.  The phenotypic spectrum of CADASIL: Clinical findings in 102 cases , 1998, Annals of neurology.

[91]  J. Weissenbach,et al.  Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients , 1997, The Lancet.

[92]  R. Powers,et al.  Transglutaminase activity is increased in Alzheimer's disease brain , 1997, Brain Research.

[93]  G. Kopen,et al.  Localization of transglutaminase in hippocampal neurons: implications for Alzheimer's disease. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[94]  J. Weissenbach,et al.  Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia , 1996, Nature.

[95]  T. Wisniewski,et al.  Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E. , 1995, The Biochemical journal.

[96]  M J Ball,et al.  beta-Amyloid-(1-42) is a major component of cerebrovascular amyloid deposits: implications for the pathology of Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[97]  O Almkvist,et al.  White-matter hyperintensity and neuropsychological functions in dementia and healthy aging. , 1992, Archives of neurology.

[98]  F. Tagliavini,et al.  Coexistence of Alzheimer's amyloid precursor protein and amyloid protein in cerebral vessel walls. , 1990, Laboratory investigation; a journal of technical methods and pathology.

[99]  M. Willingham,et al.  An Immunoperoxidase Study of Senile Cerebral Amyloidosis with Pathogenetic Considerations , 1981, Journal of neuropathology and experimental neurology.

[100]  F. Shimizu,et al.  Identification of components of immunoglobulins in senile plaques by means of fluorescent antibody technique , 1975, Acta Neuropathologica.

[101]  S. Ropele,et al.  Cortical Superficial Siderosis in Different Types of Cerebral Small Vessel Disease , 2017, Stroke.

[102]  D. Dickson,et al.  Tissue transglutaminase, protein cross-linking and Alzheimer's disease: review and views. , 2008, International journal of clinical and experimental pathology.

[103]  O. Bugiani,et al.  Thickening of the basement membrane of cortical capillaries in Alzheimer's disease , 2004, Acta Neuropathologica.

[104]  F. Verrecchia,et al.  Transforming growth factor-beta signaling through the Smad pathway: role in extracellular matrix gene expression and regulation. , 2002, The Journal of investigative dermatology.

[105]  P. Wesseling,et al.  Heparan sulfate proteoglycan expression in cerebrovascular amyloid beta deposits in Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis (Dutch) brains. , 2001, Acta neuropathologica.

[106]  D. Graham,et al.  The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. , 1999, Journal of neuropathology and experimental neurology.

[107]  R O Weller,et al.  Cerebral amyloid angiopathy: amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer's disease. , 1998, The American journal of pathology.

[108]  R N Kalaria,et al.  Cerebral vessels in ageing and Alzheimer's disease. , 1996, Pharmacology & therapeutics.

[109]  G. Glenner,et al.  Alzheimerʼs disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1988 .

[110]  S. Stergiou,et al.  Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy revisited , 2020, Neurology: Genetics.